B-CRATOS INDUSTRY PERSPECTIVES
Wireless Brain-Connect inteRfAce TO machineS
The technology developed by B-Cratos will have profound effects in several fields. In neuroprosthetics it bypasses damaged circuits in order to restore missing biological functions. It will also impact electroceuticals (modulation of organ function trough neural circuits instead of pharmaceuticals), Brain-Computer interfaces (brain plasticity trough machine learning) gaming (immersion), and Virtual Reality.
B-CRATOS is creating a new platform for fully implanted, wireless direct communication between brain-body-machine, capable of bidirectional closed-loop control.
The B-CRATOS system brings advanced communications technologies used in telecommunications and physics (such as microwave and RFID backscatter) into the human body and unites them with next-generation neural interfaces and prosthetics.
A paradigm shift is underway in medicine from the imprecise use of global pharmaceuticals (and their subsequent side-effects) to the local, targeted action of medical devices.
The B-CRATOS technologies will enable this critical transition.
Key Capabilities
- Secure, encrypted wireless intra-body data network
- 24-7 battery-less implant
- High-bandwidth, wireless record-stim neural interface
- Two-way, high-speed brain-computer link
- Self-powered electronic skin
Human Health and Market Impact
The B-CRATOS wireless platform technologies can be ported into existing in-body and closed-loop communication systems used in the Neural Disease (Alzheimer’s, dementia, chronic pain, stroke, traumatic brain injury, epilepsy, spinal cord injury, Parkinson’s), Electroceutical (organ modulation through implanted closed-loop circuits replacing pharmaceuticals), AI, Exoskeleton, Prosthetics and Robotics sectors, to dramatically increase the capability of the systems in terms of channels, speed, and data rate.
All these industries have sustainable markets with strong drivers for growth, especially as the global population ages and human lifespans are extended.
Potential markets for B-CRATOS technology include:
Neural Disease
789 B $
in 2014
8.3% compound annual growth rate (CAGR)
Invasive & Non-invasive neural interfaces
7.4 B $
by 2023
8.3% CAGR.
Sleep Apnea
5.9 B $
in 2019
7.4% CAGR.
Chronic Intractable Pain
1.5 B $
6.0% CAGR.
Electroceuticals
25.2 B $
in 2021
7.9% CAGR.
Exoskeleton
626 M $
in 2019
54.5% (CAGR)
Robotics and Automation
100 B $
in 2020
26.0% (CAGR)
AI/Deep Learning
24.9 B $
in 2018
46.2% (CAGR)
Virtual Reality and e-Learning
431 M $
in 2018
77.1% (CAGR)
Gaming and Infotainment
3.1 B $
in 2024
59.0% (CAGR)
Technology Partnership and Licensing
B-CRATOS has developed a long-term vision to work with partner affiliates and strategic associates to bring its platform and technologies to market. Through the formation of Joint Ventures between its partners and interested investors, B-CRATOS technologies will be made available for licensing agreements to create value and impact across many domains.
The following parties have provided letters of interest
Are you interested in learning more about the B-CRATOS technologies?
Please contact: Mark Schneider, B-CRATOS Project Manager
Project details:
TITLE: Wireless Brain-Connect inteRfAce TO machineS
START-END: March2021 – February 2025
EU CONTRIBUTION: €4,475,059.25
TOPIC: FETOPEN-01-2018-2019-2020: FET-Open Challenging Current Thinking
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement N° 965044